Beyond Meat plunges on 10-K delay, Q4 revenue miss
Plant-based food maker discloses material weakness in internal controls as class action lawsuits mount
Beyond Meat shares fell sharply on Monday after the plant-based food company disclosed it would delay its annual report filing and revealed a material weakness in its financial reporting controls, compounding concerns about a significant quarterly revenue shortfall.
The El Segundo, California-based company announced it would not file its 2025 Annual Report on Form 10-K by the March 16 deadline, with a new target date of March 31. The delay stems from an ongoing review of its inventory accounting practices, which the company expects will result in a material weakness in internal controls over financial reporting as of December 31, 2025.
Beyond Meat also reported preliminary fourth-quarter net revenue of approximately $61 million, missing analyst estimates of $69.8 million by 12.6%. The figure landed at the bottom of the company's own guidance range of $60 million to $65 million. Full-year revenue reached approximately $275 million, according to preliminary figures.
The disclosure triggered immediate legal scrutiny. Law firms Bronstein, Gewirtz & Grossman and Levi & Korsinsky each announced securities class action lawsuits alleging violations of federal securities laws, with investors facing a March 24 deadline to seek lead plaintiff status.
The stock, which trades with a beta of 2.66 indicating high volatility, has lost 83% from its 52-week high of $4.82 and currently sits near $0.81. The company's market capitalization has dwindled to approximately $345 million, reflecting a brutal reversal for a business that once commanded a valuation exceeding $10 billion following its 2019 initial public offering.
Beyond Meat's financial struggles have been mounting. The company reported a negative profit margin of 81.8% over the trailing twelve months and an earnings per share loss of $3.17. Revenue declined 13.3% year-over-year in the most recent quarter, according to market data, as consumer demand for plant-based meat alternatives has cooled amid broader economic pressures and increased competition from traditional food companies launching their own plant-based offerings.
Analyst sentiment remains deeply negative. Of seven analysts covering the stock, two rate it a strong sell, two recommend sell, and three maintain hold ratings, with zero buy recommendations. The consensus target price stands at $1.61, still roughly double the current share price but well below levels seen just a year ago.
The company is scheduled to report its complete fourth quarter and full-year 2025 financial results on March 25, which will provide investors with a fuller picture of the financial condition and the scope of the internal control deficiencies. The delayed 10-K filing will include audited financial statements and management's assessment of internal control over financial reporting, which will detail the remediation plans for the identified material weakness.
Beyond Meat's challenges mirror broader struggles in the plant-based food sector, which enjoyed pandemic-fueled growth but has faced headwinds as consumers prioritize affordability amid inflation. The company's book value has turned negative at -$10.22 per share, raising questions about its ability to raise additional capital if needed to fund operations while it works to stabilize its business and restore investor confidence.